Cell Banking Outsourcing Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,900	112 Pages	TechSci Research	June, 2023	TCSI18000140

Best Price Guarantee
Price	from $4,900
Length	112 Pages
Publisher	TechSci Research
Published Date	June, 2023
SKU	TCSI18000140

Cell Banking Outsourcing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking), By Cell Type (Stem Cell v/s Non-Stem Cell), By Phase (Bank Storage, Bank Characterization & Testing, Bank Preparation), By Company, and By Region

The global cell banking outsourcing market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the increase in chronic diseases, rising awareness among the parental population, and the rise in the geriatric population, which are propelling the growth of the market. Cell banking outsourcing is an ability that stores cells of a particular genome for future purposes. Cell banking outsourcing can be used to produce complete characterizations of cell lines and can also help to reduce the cross-contamination of a cell line. The other factors supporting the market's growth are extensive investments in research and development (R&D) activities, expanding the number of clinical trials, rising demand for stem cell therapies and gene therapies, rise in research activities related to stem cell applications, increasing demand for biologic products, development of advanced preservation techniques, a large number of clinical trials, and expansion of healthcare industry are bolstering the growth of the market. Also, the growing adoption of collaboration and acquisition strategies by the market players is supporting the growth of the market.

Rising Prevalence of Chronic Diseases and Increasing Geriatric Population

The increasing occurrence of chronic diseases, such as diabetes, cardiovascular diseases, and others, across the globe is strengthening the growth of the market. According to the WHO, Cardiovascular diseases (CVDs) are the leading cause of death worldwide, taking approximately 17.9 million lives each year. Stem cells are used to treat various chronic diseases as these diseases cannot be treated with traditional methods due to their adverse effect. Therefore, the use of stem cell therapy for the treatment act as a healing agent, which helps to reduce the risk or damage caused by the treatment. Owing to the continuous rise in the number of people suffering from these fatal diseases, the demand for stem cell therapies and gene therapies is rising, which is driving the growth of the market.

Increasing Geriatric Population Supports the Market

The rise in the geriatric population base across the world is surging the demand for stem cell therapy, which is impelling the growth of the market. According to the World Health Organization (WHO) data, the number and proportion of the elderly population, meaning people with age 60 years and above in the population is increasing. In 2019, the number of people aged 60 years and above was 1 billion. This number is likely to rise to 1.4 billion by 2030 and 2.1 billion by 2050.

Growing Awareness About Stem Cell Banking

Growing awareness about stem cell banking across various emerging countries is augmenting the growth of the market. Nowadays, people are becoming more aware of the benefits of stem cell banking for future purposes. Parental as well as expectant populations are becoming more aware as health specialists are starting to educate them about the significance and advantages of storing stem cells which are fueling the growth of the market globally. For instance, in the United States, the donor registry contains above 9 million potential donors. In addition, the donor registry includes 266,000 cord blood units, of which 115,000 units are from the National Cord Blood Inventory (NCBI), with over 4000 NCBI units added in 2021.

Market Segmentation

The global cell banking outsourcing market is segmented into type, cell type, Phase, and company. Based on type, the market is divided into master cell banking, working cell banking, and viral cell banking. Based on cell type, the market is divided into stem cells and non-stem cells. Based on Phase, the market is divided into bank storage, bank characterization & testing, and bank preparation. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the growing prevalence of chronic and genetic disorders in the country.

Market Players

Cryo-Cell International, Inc, Charles River Laboratories International, Inc., Goodwin Biotechnology Inc., Lonza Group AG, SGS Life Sciences (SGS SA), Global Stem Inc., BSL Bioservice Scientific Laboratories GmbH, and BioReliance Corporation are some of the leading companies operating in the market.

Report Scope:

In this report, global cell banking outsourcing market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Cell Banking Outsourcing Market, By type:
Master Cell Banking
Working Cell Banking
Viral Cell Banking
Cell Banking Outsourcing Market, By Cell Type:
Stem Cell
Non-Stem Cell
Cord Blood Banking, By Phase:
Bank Storage
Bank Characterization & Testing
Bank Preparation
Cell Banking Outsourcing Market, By Region:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
Australia
South Korea
Europe & CIS
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Turkey
Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Cell Banking Outsourcing Market

Company Information

Detailed analysis and profiling of additional market players (up to five).

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Cell Banking Outsourcing Market
5. Voice of Customer
6. Global Cell Banking Outsourcing Market Outlook: 6.1. Market Size & Forecast; 6.1.1. By Value; 6.2. Market Share & Forecast; 6.2.1. By Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking); 6.2.2. By Cell Type (Stem Cell v/s Non-Stem Cell); 6.2.3. By Phase (Bank Storage, Bank Characterization & Testing, Bank Preparation); 6.2.4. By Company (2021); 6.2.5. By Region; 6.3. Market Map
7. North America Cell Banking Outsourcing Market Outlook: 7.1. Market Size & Forecast; 7.1.1. By Value; 7.2. Market Share & Forecast; 7.2.1. By Type; 7.2.2. By Cell Type; 7.2.3. By Phase; 7.2.4. By Country; 7.3. North America: Country Analysis; 7.3.1. United States Cell Banking Outsourcing Market Outlook; 7.3.1.1. Market Size & Forecast; 7.3.1.1.1. By Value; 7.3.1.2. Market Share & Forecast; 7.3.1.2.1. By Type; 7.3.1.2.2. By Cell Type; 7.3.1.2.3. By Phase; 7.3.2. Canada Cell Banking Outsourcing Market Outlook; 7.3.2.1. Market Size & Forecast; 7.3.2.1.1. By Value; 7.3.2.2. Market Share & Forecast; 7.3.2.2.1. By Type; 7.3.2.2.2. By Cell Type; 7.3.2.2.3. By Phase; 7.3.3. Mexico Cell Banking Outsourcing Market Outlook; 7.3.3.1. Market Size & Forecast; 7.3.3.1.1. By Value; 7.3.3.2. Market Share & Forecast; 7.3.3.2.1. By Type; 7.3.3.2.2. By Cell Type; 7.3.3.2.3. By Phase
8. Europe Cell Banking Outsourcing Market Outlook: 8.1. Market Size & Forecast; 8.1.1. By Value; 8.2. Market Share & Forecast; 8.2.1. By Type; 8.2.2. By Cell Type; 8.2.3. By Phase; 8.2.4. By Country; 8.3. Europe: Country Analysis; 8.3.1. France Cell Banking Outsourcing Market Outlook; 8.3.1.1. Market Size & Forecast; 8.3.1.1.1. By Value; 8.3.1.2. Market Share & Forecast; 8.3.1.2.1. By Type; 8.3.1.2.2. By Cell Type; 8.3.1.2.3. By Phase; 8.3.2. Germany Cell Banking Outsourcing Market Outlook; 8.3.2.1. Market Size & Forecast; 8.3.2.1.1. By Value; 8.3.2.2. Market Share & Forecast; 8.3.2.2.1. By Type; 8.3.2.2.2. By Cell Type; 8.3.2.2.3. By Phase; 8.3.3. United Kingdom Cell Banking Outsourcing Market Outlook; 8.3.3.1. Market Size & Forecast; 8.3.3.1.1. By Value; 8.3.3.2. Market Share & Forecast; 8.3.3.2.1. By Type; 8.3.3.2.2. By Cell Type; 8.3.3.2.3. By Phase; 8.3.4. Italy Cell Banking Outsourcing Market Outlook; 8.3.4.1. Market Size & Forecast; 8.3.4.1.1. By Value; 8.3.4.2. Market Share & Forecast; 8.3.4.2.1. By Type; 8.3.4.2.2. By Cell Type; 8.3.4.2.3. By Phase; 8.3.5. Spain Cell Banking Outsourcing Market Outlook; 8.3.5.1. Market Size & Forecast; 8.3.5.1.1. By Value; 8.3.5.2. Market Share & Forecast; 8.3.5.2.1. By Type; 8.3.5.2.2. By Cell Type; 8.3.5.2.3. By Phase
9. Asia-Pacific Cell Banking Outsourcing Market Outlook: 9.1. Market Size & Forecast; 9.1.1. By Value; 9.2. Market Share & Forecast; 9.2.1. By Type; 9.2.2. By Cell Type; 9.2.3. By Phase; 9.2.4. By Country; 9.3. Asia-Pacific: Country Analysis; 9.3.1. China Cell Banking Outsourcing Market Outlook; 9.3.1.1. Market Size & Forecast; 9.3.1.1.1. By Value; 9.3.1.2. Market Share & Forecast; 9.3.1.2.1. By Type; 9.3.1.2.2. By Cell Type; 9.3.1.2.3. By Phase; 9.3.2. India Cell Banking Outsourcing Market Outlook; 9.3.2.1. Market Size & Forecast; 9.3.2.1.1. By Value; 9.3.2.2. Market Share & Forecast; 9.3.2.2.1. By Type; 9.3.2.2.2. By Cell Type; 9.3.2.2.3. By Phase; 9.3.3. Japan Cell Banking Outsourcing Market Outlook; 9.3.3.1. Market Size & Forecast; 9.3.3.1.1. By Value; 9.3.3.2. Market Share & Forecast; 9.3.3.2.1. By Type; 9.3.3.2.2. By Cell Type; 9.3.3.2.3. By Phase; 9.3.4. South Korea Cell Banking Outsourcing Market Outlook; 9.3.4.1. Market Size & Forecast; 9.3.4.1.1. By Value; 9.3.4.2. Market Share & Forecast; 9.3.4.2.1. By Type; 9.3.4.2.2. By Cell Type; 9.3.4.2.3. By Phase; 9.3.5. Australia Cell Banking Outsourcing Market Outlook; 9.3.5.1. Market Size & Forecast; 9.3.5.1.1. By Value; 9.3.5.2. Market Share & Forecast; 9.3.5.2.1. By Type; 9.3.5.2.2. By Cell Type; 9.3.5.2.3. By Phase
10. South America Cell Banking Outsourcing Market Outlook: 10.1. Market Size & Forecast; 10.1.1. By Value; 10.2. Market Share & Forecast; 10.2.1. By Type; 10.2.2. By Cell Type; 10.2.3. By Phase; 10.2.4. By Country; 10.3. South America: Country Analysis; 10.3.1. Brazil Cell Banking Outsourcing Market Outlook; 10.3.1.1. Market Size & Forecast; 10.3.1.1.1. By Value; 10.3.1.2. Market Share & Forecast; 10.3.1.2.1. By Type; 10.3.1.2.2. By Cell Type; 10.3.1.2.3. By Phase; 10.3.2. Argentina Cell Banking Outsourcing Market Outlook; 10.3.2.1. Market Size & Forecast; 10.3.2.1.1. By Value; 10.3.2.2. Market Share & Forecast; 10.3.2.2.1. By Type; 10.3.2.2.2. By Cell Type; 10.3.2.2.3. By Phase; 10.3.3. Colombia Cell Banking Outsourcing Market Outlook; 10.3.3.1. Market Size & Forecast; 10.3.3.1.1. By Value; 10.3.3.2. Market Share & Forecast; 10.3.3.2.1. By Type; 10.3.3.2.2. By Cell Type; 10.3.3.2.3. By Phase
11. Middle East and Africa Cell Banking Outsourcing Market Outlook: 11.1. Market Size & Forecast; 11.1.1. By Value; 11.2. Market Share & Forecast; 11.2.1. By Type; 11.2.2. By Cell Type; 11.2.3. By Phase; 11.2.4. By Country; 11.3. MEA: Country Analysis; 11.3.1. South Africa Cell Banking Outsourcing Market Outlook; 11.3.1.1. Market Size & Forecast; 11.3.1.1.1. By Value; 11.3.1.2. Market Share & Forecast; 11.3.1.2.1. By Type; 11.3.1.2.2. By Cell Type; 11.3.1.2.3. By Phase; 11.3.2. Saudi Arabia Cell Banking Outsourcing Market Outlook; 11.3.2.1. Market Size & Forecast; 11.3.2.1.1. By Value; 11.3.2.2. Market Share & Forecast; 11.3.2.2.1. By Type; 11.3.2.2.2. By Cell Type; 11.3.2.2.3. By Phase; 11.3.3. UAE Cell Banking Outsourcing Market Outlook; 11.3.3.1. Market Size & Forecast; 11.3.3.1.1. By Value; 11.3.3.2. Market Share & Forecast; 11.3.3.2.1. By Type; 11.3.3.2.2. By Cell Type; 11.3.3.2.3. By Phase; 11.3.4. Turkey Cell Banking Outsourcing Market Outlook; 11.3.4.1. Market Size & Forecast; 11.3.4.1.1. By Value; 11.3.4.2. Market Share & Forecast; 11.3.4.2.1. By Type; 11.3.4.2.2. By Cell Type; 11.3.4.2.3. By Phase; 11.3.5. Egypt Cell Banking Outsourcing Market Outlook; 11.3.5.1. Market Size & Forecast; 11.3.5.1.1. By Value; 11.3.5.2. Market Share & Forecast; 11.3.5.2.1. By Type; 11.3.5.2.2. By Cell Type; 11.3.5.2.3. By Phase
12. Market Dynamics: 12.1. Drivers; 12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape: 14.1. Cryo-Cell International, Inc; 14.2. Charles River Laboratories International, Inc.; 14.3. Goodwin Biotechnology Inc.; 14.4. Lonza Group AG; 14.5. SGS Life Sciences (SGS SA); 14.6. Global Stem Inc.; 14.7. BSL Bioservice Scientific Laboratories GmbH; 14.8. BioReliance Corporation
15. Strategic Recommendations